| Peer-Reviewed

Prinzmetal Angina in Major Hemophilia a Patient: A Case Report

Received: 4 July 2015     Accepted: 14 July 2015     Published: 31 July 2015
Views:       Downloads:
Abstract

Introduction: Prinzmetal angina is a special type of acute coronary syndrome ST+ wich correspond to a transient occlusion of a coronary vessel secondary to spasm. This type of acute coronary syndrome is very rare and is characterized by the presence of signs of myocardial ischemia on electrocardiogram but coronary angiography and coroscaner are frequently normals. Its management in hemophilia patients is difficult because of the use of anticoagulant and antiplatelet drugs wich increase bleeding risk. We report the case of a major hemophilia A patient which presented Prinzmetal angina. Observation : It is a 64 years old patient, hemophilia A major, chronic smoking (40 pack-year), not diabetic, not hypertensive, which had a retro sternal constrictive pain radiating to the shoulders. At admission he was consciousness. No breath in cardiac auscultation. The electrocardiography showed a heart rate at 61bpm, the axis of the heart was normal. ST-segment elevation was noticed in DIII and AVF : ischemia in the cardiac lower area. Echocardiography was normal. The coroscaner was normal. The troponin I level was at 0.03 µg / L (Normal : 0-0.1µg/L). This patient had a variant Prinzmetal angina. Treatement: Diltiazem Hydrochloride 60 mg 1 tablet / 8 hours. Acetylsalicylic acid 160 mg IV and Clopidogrel 300 mg IV the first day ; relay with acetylsalicylic acid 100 mg and clopidogrel 75 mg per day. Transfusion of factor VIII at the dose of 40UI / Kg. Simvastatin 20 mg 1 tablet per day. Perindopril 5 mg 1 tablet the day. The evolution was favorable. Discussion and conclusion: Coronary syndromes are not frequent in morocco hemophilia patients. Their management is complex and involves the presence of an hematologist.

Published in American Journal of Internal Medicine (Volume 3, Issue 4)
DOI 10.11648/j.ajim.20150304.17
Page(s) 194-196
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2015. Published by Science Publishing Group

Keywords

Acute Coronary Syndrome, Hemophilia, Management

References
[1] Darby SC, Wan Kan S, Spooner RJ et al. Mortality rates, life expectancy, and causes of death in people with hemophilia A or B in the United Kingdom who where not infected with HIV. Blood 2007;110:815-25.
[2] Cayla G, Morange PE, Chambost H, Schved JF. Hémophilie et pathologies cardiovasculaires. AMC pratique. Hors-série 1. Juin 2010 : 1-3
[3] Kulkarni R, Soucie JM, Evatt BL, Hemophilia Surveillance System Project Investigators. Prevalence and risk factors for heart disease among males with hemophilia. Am J Hematol 2005;79:36-42.
[4] Prinzmetal M, Kennamer R, Merliss R, et al. Angina pectoris. A variant form of angina pectoris; preliminary report. Am J Med. 1959;27:375e388.
[5] Chahine RA, Raizner AE, Ishimori T, et al. The incidence and clinical implications of coronary artery spasm. Circulation. 1975;52:972e978.
[6] Feliciano L, Henning R. Coronary artery blood flow: physiologic and pathophysiologic regulation. Clin Cardiol 1999;22:775 – 86.
[7] Kelm M, Schrader J. Control of coronary vascular tone by nitric oxide. Circ Res 1990;66:1561 – 75.
[8] Bassand JP, Hamm CW, Ardissino D et al. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. Eur Heart J. 2007;28:1598-660.
[9] Van de Werf F, Bax J, Betriu A et al. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 2008;29:2909-45.
[10] Staritz P, de Moerloose P, Schutgens R, Dolan G. Applicability of the European Society of Cardiology guidelines on management of acute coronary syndromes to people with haemophilia - an assessment by the ADVANCE Working Group. Haemophilia. 2013 Nov;19(6):833-40.
[11] Fogarty PF, Mancuso ME, Kasthuri R, Bidlingmaier C, Chitlur M, Gomez K, et al. Presentation and management of acute coronary syndromes among adult persons with haemophilia: result of an international, retrospective, 10-years survey. Haemophilia. 2015 Feb 17. Doi: 10. 1111/hae.12652.
[12] Mannucci PM. Management of antithrombotic therapy for acute coronary syndromes and atrial fibrillation in patients with hemophilia. Expert Opin Pharmacother 2012;13: 505-10.
[13] Anderson JL, Adams CD, Antman ME, Bridges CH, Califf RM, Donald E, et al. 2012 ACCF/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2013; 127: e663-828.
Cite This Article
  • APA Style

    Romaric Mahutondji Massi, Bienvenu Houssou, Marième Camara, Nisrine Khoubila, Asma Quessar, et al. (2015). Prinzmetal Angina in Major Hemophilia a Patient: A Case Report. American Journal of Internal Medicine, 3(4), 194-196. https://doi.org/10.11648/j.ajim.20150304.17

    Copy | Download

    ACS Style

    Romaric Mahutondji Massi; Bienvenu Houssou; Marième Camara; Nisrine Khoubila; Asma Quessar, et al. Prinzmetal Angina in Major Hemophilia a Patient: A Case Report. Am. J. Intern. Med. 2015, 3(4), 194-196. doi: 10.11648/j.ajim.20150304.17

    Copy | Download

    AMA Style

    Romaric Mahutondji Massi, Bienvenu Houssou, Marième Camara, Nisrine Khoubila, Asma Quessar, et al. Prinzmetal Angina in Major Hemophilia a Patient: A Case Report. Am J Intern Med. 2015;3(4):194-196. doi: 10.11648/j.ajim.20150304.17

    Copy | Download

  • @article{10.11648/j.ajim.20150304.17,
      author = {Romaric Mahutondji Massi and Bienvenu Houssou and Marième Camara and Nisrine Khoubila and Asma Quessar and Bouchra Oukkache},
      title = {Prinzmetal Angina in Major Hemophilia a Patient: A Case Report},
      journal = {American Journal of Internal Medicine},
      volume = {3},
      number = {4},
      pages = {194-196},
      doi = {10.11648/j.ajim.20150304.17},
      url = {https://doi.org/10.11648/j.ajim.20150304.17},
      eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajim.20150304.17},
      abstract = {Introduction: Prinzmetal angina is a special type of acute coronary syndrome ST+ wich correspond to a transient occlusion of a coronary vessel secondary to spasm. This type of acute coronary syndrome is very rare and is characterized by the presence of signs of myocardial ischemia on electrocardiogram but coronary angiography and coroscaner are frequently normals. Its management in hemophilia patients is difficult because of the use of anticoagulant and antiplatelet drugs wich increase bleeding risk. We report the case of a major hemophilia A patient which presented Prinzmetal angina. Observation : It is a 64 years old patient, hemophilia A major, chronic smoking (40 pack-year), not diabetic, not hypertensive, which had a retro sternal constrictive pain radiating to the shoulders. At admission he was consciousness. No breath in cardiac auscultation. The electrocardiography showed a heart rate at 61bpm, the axis of the heart was normal. ST-segment elevation was noticed in DIII and AVF : ischemia in the cardiac lower area. Echocardiography was normal. The coroscaner was normal. The troponin I level was at 0.03 µg / L (Normal : 0-0.1µg/L). This patient had a variant Prinzmetal angina. Treatement: Diltiazem Hydrochloride 60 mg 1 tablet / 8 hours. Acetylsalicylic acid 160 mg IV and Clopidogrel 300 mg IV the first day ; relay with acetylsalicylic acid 100 mg and clopidogrel 75 mg per day. Transfusion of factor VIII at the dose of 40UI / Kg. Simvastatin 20 mg 1 tablet per day. Perindopril 5 mg 1 tablet the day. The evolution was favorable. Discussion and conclusion: Coronary syndromes are not frequent in morocco hemophilia patients. Their management is complex and involves the presence of an hematologist.},
     year = {2015}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - Prinzmetal Angina in Major Hemophilia a Patient: A Case Report
    AU  - Romaric Mahutondji Massi
    AU  - Bienvenu Houssou
    AU  - Marième Camara
    AU  - Nisrine Khoubila
    AU  - Asma Quessar
    AU  - Bouchra Oukkache
    Y1  - 2015/07/31
    PY  - 2015
    N1  - https://doi.org/10.11648/j.ajim.20150304.17
    DO  - 10.11648/j.ajim.20150304.17
    T2  - American Journal of Internal Medicine
    JF  - American Journal of Internal Medicine
    JO  - American Journal of Internal Medicine
    SP  - 194
    EP  - 196
    PB  - Science Publishing Group
    SN  - 2330-4324
    UR  - https://doi.org/10.11648/j.ajim.20150304.17
    AB  - Introduction: Prinzmetal angina is a special type of acute coronary syndrome ST+ wich correspond to a transient occlusion of a coronary vessel secondary to spasm. This type of acute coronary syndrome is very rare and is characterized by the presence of signs of myocardial ischemia on electrocardiogram but coronary angiography and coroscaner are frequently normals. Its management in hemophilia patients is difficult because of the use of anticoagulant and antiplatelet drugs wich increase bleeding risk. We report the case of a major hemophilia A patient which presented Prinzmetal angina. Observation : It is a 64 years old patient, hemophilia A major, chronic smoking (40 pack-year), not diabetic, not hypertensive, which had a retro sternal constrictive pain radiating to the shoulders. At admission he was consciousness. No breath in cardiac auscultation. The electrocardiography showed a heart rate at 61bpm, the axis of the heart was normal. ST-segment elevation was noticed in DIII and AVF : ischemia in the cardiac lower area. Echocardiography was normal. The coroscaner was normal. The troponin I level was at 0.03 µg / L (Normal : 0-0.1µg/L). This patient had a variant Prinzmetal angina. Treatement: Diltiazem Hydrochloride 60 mg 1 tablet / 8 hours. Acetylsalicylic acid 160 mg IV and Clopidogrel 300 mg IV the first day ; relay with acetylsalicylic acid 100 mg and clopidogrel 75 mg per day. Transfusion of factor VIII at the dose of 40UI / Kg. Simvastatin 20 mg 1 tablet per day. Perindopril 5 mg 1 tablet the day. The evolution was favorable. Discussion and conclusion: Coronary syndromes are not frequent in morocco hemophilia patients. Their management is complex and involves the presence of an hematologist.
    VL  - 3
    IS  - 4
    ER  - 

    Copy | Download

Author Information
  • Departement of Biological Hematology of Ibn Rochd University Hospital, Casablanca, Morocco

  • Departement of Biological Hematology of Ibn Rochd University Hospital, Casablanca, Morocco

  • Departement of Biological Hematology of Ibn Rochd University Hospital, Casablanca, Morocco

  • Departement of Clinical Hematology and Pediatric Oncology of Ibn Rochd University Hospital, Casablanca, Morocco

  • Departement of Clinical Hematology and Pediatric Oncology of Ibn Rochd University Hospital, Casablanca, Morocco

  • Departement of Biological Hematology of Ibn Rochd University Hospital, Casablanca, Morocco

  • Sections